Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Tissue Expansion;”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)WithdrawnNCT04655183
What this trial is testing

Study of M4344 in Combination With Niraparib

Who this might be right for
Advanced Solid TumorBreast Cancer
EMD Serono Research & Development Institute, Inc.
Early research (Phase 1)Ended earlyNCT05385705
What this trial is testing

Allogenic Natural Killer Cells in Combination With Trastuzumab and Pertuzumab in Adult Patients With Refractory Metastatic Her2 Positive Breast Cancer. NK-ACT-BC_2020

Who this might be right for
Breast Neoplasms
Vall d'Hebron Institute of Oncology 2
Testing effectiveness (Phase 2)UnknownNCT06224387
What this trial is testing

CTS2190 Phase I /II Clinical Study in Patients

Who this might be right for
Solid TumorsPancreatic CancerNon-small Cell Lung Cancer+1 more
CytosinLab Therapeutics Co., Ltd. 224
Testing effectiveness (Phase 2)Study completedNCT04095221
What this trial is testing

The Drugs Prexasertib, Irinotecan, and Temozolomide in People With Desmoplastic Small Round Cell Tumor and Rhabdomyosarcoma

Who this might be right for
Desmoplastic Small Round Cell TumorRhabdomyosarcoma
Memorial Sloan Kettering Cancer Center 21
Early research (Phase 1)Study completedNCT03761017
What this trial is testing

MGD019 DART® Protein in Unresectable/Metastatic Cancer

Who this might be right for
Squamous Cell Non Small Cell Lung CancerProstate Cancer MetastaticCutaneous Melanoma+3 more
MacroGenics 162
Early research (Phase 1)Study completedNCT01537744
What this trial is testing

A Trial of Oral 5-azacitidine in Combination With Romidepsin in Advanced Solid Tumors, With an Expansion Cohort in Virally Mediated Cancers and Liposarcoma

Who this might be right for
Solid TumorsVirally Mediated Cancers and Liposarcoma
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 18
Not applicableStudy completedNCT07179354
What this trial is testing

Comparative 3D Assessment of Class III Malocclusion Treatments

Who this might be right for
Class III Skeletal Malocclusion
TC Erciyes University 55
Early research (Phase 1)Study completedNCT01363232
What this trial is testing

Safety, Pharmacokinetics and Pharmacodynamics of BKM120 Plus MEK162 in Selected Advanced Solid Tumor Patients

Who this might be right for
Advanced Solid TumorsSelected Solid Tumors
Array Biopharma, now a wholly owned subsidiary of Pfizer 89
Early research (Phase 1)Temporarily pausedNCT05958199
What this trial is testing

NPX267 for Subjects With Solid Tumors Known to Express HHLA2/B7-H7

Who this might be right for
Metastatic Malignant Neoplasm
NextPoint Therapeutics, Inc. 131
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07604285
What this trial is testing

Safety and Tolerability of MT-125 With Chemoradiation in Patients With Newly Diagnosed MGMT Methylated Glioblastoma

Who this might be right for
Glioblastoma
Myosin Therapeutics Inc. 36
Early research (Phase 1)Study completedNCT02077933
What this trial is testing

Study of Safety and Efficacy of Alpelisib With Everolimus or Alpelisib With Everolimus and Exemestane in Advanced Breast Cancer Patients, Renal Cell Cancer and Pancreatic Tumors

Who this might be right for
NeoplasmsBreast NeoplasmsKidney Neoplasms+1 more
Novartis Pharmaceuticals 79
Testing effectiveness (Phase 2)Looking for participantsNCT07339176
What this trial is testing

Intratumoral N17350 in Advanced Solid Tumors

Who this might be right for
Neoplasms, Solid TumorBreast Neoplasms, Triple-NegativeSquamous Cell Carcinoma of Skin+4 more
Onchilles Pharma Inc 275
Early research (Phase 1)Study completedNCT02051751
What this trial is testing

Evaluate the Potential Benefit of the Addition of BYL719 to Paclitaxel in the Treatment of Breast Cancer and Head-and-neck Cancer

Who this might be right for
Neoplasms, Breast Neoplasms, Head and Neck Neoplasms
Novartis Pharmaceuticals 19
Early research (Phase 1)Active Not RecruitingNCT05238883
What this trial is testing

HFB200301 as a Single Agent and in Combination With Tislelizumab in Adult Patients With Advanced Solid Tumors

Who this might be right for
Gastric CancerRenal Cell CarcinomaMelanoma+6 more
HiFiBiO Therapeutics 72
Early research (Phase 1)Looking for participantsNCT04890613
What this trial is testing

Study of CX-5461 in Patients With Solid Tumours and BRCA1/2, PALB2 or Homologous Recombination Deficiency (HRD) Mutation

Who this might be right for
Advanced Solid Tumor
Senhwa Biosciences, Inc. 52
Early research (Phase 1)Looking for participantsNCT06440005
What this trial is testing

Evaluate Safety, Tolerability and Preliminary Activity of AGX101 in Participants With Advanced Solid Tumors

Who this might be right for
CancerAdvanced CancerLocally Advanced Carcinoma+8 more
Angiex, Inc. 80
Very early researchEnded earlyNCT04424966
What this trial is testing

Infigratinib in Recurrent High-Grade Glioma Patients

Who this might be right for
GliomaGlioblastomaGBM
Nader Sanai 7
Testing effectiveness (Phase 2)Study completedNCT03321929
What this trial is testing

Intraoperative Detection of Residual Cancer in Breast Cancer

Who this might be right for
Breast Cancer
Lumicell, Inc. 234
Testing effectiveness (Phase 2)Study completedNCT00526045
What this trial is testing

Phase I-II Study to Determine the Maximum Tolerated Dose (MTD) of AUY922 in Advanced Solid Malignancies, and Efficacy in HER2+ or ER+ Locally Advanced or Metastatic Breast Cancer Patients

Who this might be right for
Breast CancerHematologic Neoplasms
Novartis Pharmaceuticals 117
Early research (Phase 1)Study completedNCT02437227
What this trial is testing

Dose Escalation Study With Expansion to Evaluate Safety, Tolerability, Pharmacokinetics & Pharmacodynamics of CCT3833

Who this might be right for
MelanomaCancer
Royal Marsden NHS Foundation Trust 31
Next Page